To access the conference call, please dial:
International toll: | +65.6723.9381 |
United States toll-free: | +1.866.519.4004 |
United States toll: | +1.718.354.1231 |
China Domestic toll: | 800.819.0121 |
China Domestic mobile toll: | 400.620.8038 |
Hong Kong toll: | +852.2475.0994 |
Please ask to be connected to Q1 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 58031483.
Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.
Following the earnings conference call, an archive of the call will be available by dialing:
United States toll-free: | +1. 855.452.5696 |
United States toll: | +1. 646.254.3697 |
The passcode for replay participants is 58031483. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.
About Simcere Pharmaceutical Group
Simcere Pharmaceutical Group (NYSE:SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in
Investor and Media Contacts:
Email: ir@simcere.com | |
In Nanjing: Jie Liu D'Elia Vice President Simcere Pharmaceutical Group Tel: 86-25-8556-6666*8857 | In the United States: Cindy Zheng Brunswick Group Tel: 1-212-333-3810 |
In Beijing: Yue Yu Brunswick Group Tel: 86-10-5960-8600 |
SOURCE Simcere Pharmaceutical Group